Premium
Low rates of diagnostic colonoscopy in Federally Qualified Health Centers: A persistent problem that must be addressed to achieve the promise of colorectal cancer screening
Author(s) -
Myers Ronald E.
Publication year - 2019
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32438
Subject(s) - medicine , colonoscopy , referral , colorectal cancer , colorectal cancer screening , diagnostic test , cancer screening , intensive care medicine , test (biology) , cancer , family medicine , pediatrics , paleontology , biology
The complete diagnostic evaluation of patients who have abnormal colorectal cancer screening stool blood test results has been and continues to be suboptimal, especially in underserved patient populations. In this issue of Cancer , Bharti et al document this problem in Federally Qualified Health Centers and highlight the need to understand patient and system barriers to complete diagnostic evaluation adherence after referral and the importance of identifying strategies to maximize complete diagnostic evaluation performance. Attention should also be devoted to making evidence‐based stool blood tests available to patients who choose not to undergo screening colonoscopy.